Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Vanina, Y.
* Articles by Lippmann, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Vanina, Y.
* Articles by Lippmann, S.
Related Collections
* Patient Satisfaction, Quality of Life
* Atypical Neuroleptics
* Conventional Neuroleptics
* Antidepressants
* Lithium
Psychiatr Serv 53:842-847, July 2002
© 2002 American Psychiatric Association


Other Articles

Body Weight Changes Associated With Psychopharmacology

Yelena Vanina, M.D., Anna Podolskaya, M.D., Karim Sedky, M.D., Hasan Shahab, M.D., Abufarah Siddiqui, M.D., Firoz Munshi, M.D. and Steven Lippmann, M.D.

OBJECTIVE: The authors discuss changes in body weight associated with various psychopharmaceuticals. METHODS: A large number of articles and books about drug-induced changes in body weight, selected on the basis of various literature searches and the authors' clinical experiences with psychopharmaceuticals, were reviewed. RESULTS: Many psychotropic drugs with antipsychotic, mood stabilizing, and antidepressant properties are associated with weight gain. Others, such as fluoxetine, isocarboxazid, nefazadone, topiramate, and psychostimulants, may cause weight loss. The antipsychotic drugs chlorpromazine, clozapine, and olanzapine are often associated with weight gain. Among antidepressants, amitriptyline and mirtazapine are known to cause weight gain. However, reductions are sometimes observed, and each antidepressant has its own unique weight-effect profile. Mood stabilizers, especially valproate-related products, are also associated with weight gain. CONCLUSIONS: Careful monitoring and consideration of alternative therapies are essential.




This article has been cited by other articles:


Home page
J Health PsycholHome page
B. Blaine
Does Depression Cause Obesity?: A Meta-analysis of Longitudinal Studies of Depression and Weight Control
J Health Psychol, November 1, 2008; 13(8): 1190 - 1197.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
S. Park, S. Hong, J. Lee, S. Sung, and S. Kim
Chlorpromazine attenuates pancreatic {beta}-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation
J Psychopharmacol, July 1, 2008; 22(5): 522 - 531.
[Abstract] [PDF]


Home page
CMAJHome page
S. Kisely, M. Smith, D. Lawrence, M. Cox, L. A. Campbell, and S. Maaten
Inequitable access for mentally ill patients to some medically necessary procedures
Can. Med. Assoc. J., March 13, 2007; 176(6): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
M. M. Huizinga and A. Peltier
Painful Diabetic Neuropathy: A Management-Centered Review
Clin. Diabetes, January 1, 2007; 25(1): 6 - 15.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. L. Collazo-Clavell, M. M. Clark, D. E. McAlpine, and M. D. Jensen
Assessment and Preparation of Patients for Bariatric Surgery
Mayo Clin. Proc., October 1, 2006; 81(10_Suppl): S11 - S17.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
S. Kisely, M. Smith, D. Lawrence, and S. Maaten
Mortality in individuals who have had psychiatric treatment: Population-based study in Nova Scotia
The British Journal of Psychiatry, December 1, 2005; 187(6): 552 - 558.
[Abstract] [Full Text] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
C. Kennedy, P. Salsberry, J. Nickel, C. Hunt, and E. Chipps
The Burden of Disease in Those With Serious Mental and Physical Illnesses
Journal of the American Psychiatric Nurses Association, February 1, 2005; 11(1): 45 - 51.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Lagace and M. W. Nachtigal
Inhibition of Histone Deacetylase Activity by Valproic Acid Blocks Adipogenesis
J. Biol. Chem., April 30, 2004; 279(18): 18851 - 18860.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
L. P. Richardson, R. Davis, R. Poulton, E. McCauley, T. E. Moffitt, A. Caspi, and F. Connell
A Longitudinal Evaluation of Adolescent Depression and Adult Obesity
Arch Pediatr Adolesc Med, August 1, 2003; 157(8): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. NewsHome page
J. Rosack
New Studies Raise Questions About Antipsychotic Efficacy
Psychiatr News, July 4, 2003; 38(13): 18 - 19.
[Full Text]


Home page
BMJHome page
S. Garattini, V. Bertele, and L. L. Bassi
How can research ethics committees protect patients better?
BMJ, May 29, 2003; 326(7400): 1199 - 1201.
[Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Altering Minds, Altering Bodies
Journal Watch Women's Health, September 24, 2002; 2002(924): 6 - 6.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org